pyrazinamide has been researched along with MODS in 2 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reisinger, AC | 1 |
| Hermann, J | 1 |
| Vagena, FR | 1 |
| Hackl, G | 1 |
| Eller, P | 1 |
| Martínez de Lagrán, I | 1 |
| Marcos, P | 1 |
| Batlle, M | 1 |
| Alonso, E | 1 |
| Plana, A | 1 |
| Tomasa, T | 1 |
2 other studies available for pyrazinamide and MODS
| Article | Year |
|---|---|
Tuberculosis sepsis after tocilizumab treatment.
Topics: Antibodies, Monoclonal, Humanized; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; | 2020 |
Leukapheresis in the management of drug rash with eosinophilia and systemic symptoms syndrome.
Topics: Antitubercular Agents; Combined Modality Therapy; Drug Combinations; Drug Hypersensitivity Syndrome; | 2017 |